IDEAYA BIOSCIENCES, INC. logo

IDEAYA BIOSCIENCES, INC.

7 Marks
Corp.
First Filed:Aug 26, 2016Latest Filed:Nov 6, 2023Address:5000 Shoreline Ct, Suite 300, South San Francisco, CA 94080, US

Portfolio Overview

Registered
1(14%)
Pending
6(86%)

Top Classes

Class 5
Pharmaceuticals
7(100%)

TTAB Proceedings

No litigation activity

Top Firms

MINTZ, LEVIN, COHN, FERRIS, ...(Nov 2023)
6
Lathrop GPM LLP(Aug 2016)
1

Trademark Portfolio

7 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
IMCLISFA
IMCLISFA
Trademark
Word
ITU
PENDING
Owner:
Serial:98257351
Filed:Nov 6, 2023
Classes:5
Goods & Services
Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes
IPIKCYA
IPIKCYA
Trademark
Word
ITU
PENDING
Owner:
Serial:98257328
Filed:Nov 6, 2023
Classes:5
Goods & Services
Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes
OMCLISOS
OMCLISOS
Trademark
Word
ITU
PENDING
Owner:
Serial:98257321
Filed:Nov 6, 2023
Classes:5
Goods & Services
Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes
OMCLISVI
OMCLISVI
Trademark
Word
ITU
PENDING
Owner:
Serial:98257360
Filed:Nov 6, 2023
Classes:5
Goods & Services
Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes
UMDARZI
UMDARZI
Trademark
Word
ITU
PENDING
Owner:
Serial:98257358
Filed:Nov 6, 2023
Classes:5
Goods & Services
Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes
UMDARZY
UMDARZY
Trademark
Word
ITU
PENDING
Owner:
Serial:98257354
Filed:Nov 6, 2023
Classes:5
Goods & Services
Pharmaceutical and biological preparations, namely, an orally administered protein kinase C (PKC) inhibitor for treating cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for use in oncology for medical treatment purposes; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing cancer, tumors, melanoma, and carcinoma; pharmaceutical and biological preparations for preventing, diagnosing, treating and managing metastatic uveal melanoma, primary uveal melanoma, and cutaneous melanoma; therapeutic agents for targeting genetically defined cancers or tumors having GNAQ or GNA11 gene mutations, and destruction of diseased cells, for medical treatment purposes
IDEAYA
IDEAYA
Trademark
Word
REGISTERED
Owner:
Serial:87152601
Filed:Aug 26, 2016
Classes:5
Registration:5643971
Registered:Jan 1, 2019
Goods & Services
Small molecule therapeutic pharmaceuticals for the treatment of cancer

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.

View our privacy policy